| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Aquilo Capital Management, LLC is a 10% Owner at PVLA, with reported holdings spanning 2 companies. Recent filings cover 27 purchases and 14 sales. Those positions are worth an estimated $18.5M at current prices.
Our model assigns Aquilo Capital Management, LLC a below-average insider score of 33/100, based on 25 past trades. Over a 12-month horizon, 4.0% of those trades were profitable, with an average 12-month return of -83.3%.
Aquilo Capital Management, LLC's largest disclosed position is in PVLA as 10% Owner, worth about $10.8M. The recent filings there lean toward selling, a net 1,900,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2020 | SPRO Spero Therapeutics, Inc. | 10% Owner | Sell | 264,933 | $18.80 | $4,981,259.54 | -6.3% | |
| Nov 9, 2020 | SPRO Spero Therapeutics, Inc. | 10% Owner | Sell | 125,900 | $13.77 | $1,734,071.06 | -2.9% | |
| Nov 6, 2020 | SPRO Spero Therapeutics, Inc. | 10% Owner | Sell | 174,100 | $14.09 | $2,452,947.51 | -3.9% | |
| Jul 21, 2020 | PVLA Palvella Therapeutics, Inc. | 10% Owner | Sell | 1,900,000 | $2.95 | $5,605,000.00 | -34.1% |